Navigation Links
China Sky One Medical's CEO Receives Award For "Leadership Excellence In Innovation"

HARBIN, China, May 14 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that Mr. Yan-Qing Liu, the Company's Chairman and Chief Executive Officer, received the award for "Leadership Excellence in Innovation" from the organizing committee of China Enterprise Innovation Forum.

Mr. Liu will attend the 10th China Enterprise Innovation Forum and the award ceremony held in Beijing on June 6, 2010. The Enterprise Innovation Forum is sponsored by a number of industry associations, including the Chinese Association for Productivity & Science, which was established under the approval of China's Ministry of Civil Affairs in 1980. There will be over 500 attendees including senior government officials, economists, business leaders as well as journalists. Each year in China, this award is presented to up to 50 business leaders who have demonstrated leadership in driving innovation at their companies and generating considerable economic benefits.

"I accept this honor on behalf of all the employees at China Sky One Medical who have helped to drive the Company's innovative advances over the years. We will continue our focus on developing and commercializing novel medical technologies and drugs to help physicians and patients, and create long term value for our shareholders," said Mr. Liu.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include the innovation activities and its effect on the Company's operational results. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the ability to develop new technologies and products, market acceptance of new product launches, achievability of management's estimates of product sales, the effect of changing economic conditions in The People's Republic of China, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:

     China Sky One Medical, Inc.
     Mr. Stanley Hao, CFO
     Tel:   +86-0451-87032617

    Investor Relations Contact:

     CCG Investor Relations
     Ms. Lei Huang, Account Manager
     Tel:     +1-646-833-3417

     Ms. Mabel Zhang, Vice President
     Tel:   +1-310-954-1353

SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical to Attend Investment Conferences in May
2. China Biologic Products to Build Two New Plasma Stations in Shandong Province
3. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
4. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
5. China Pharma Holdings, Inc. Announces May Investor Conference Participation
6. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
7. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
8. China Pharma Holdings, Inc. Retains CCG Investor Relations
9. China Medical Technologies to Participate in Investor Conferences in May and June 2010
10. Winner Medical Participates in CMEF 2010, China International Medical Equipment Fair, in Shenzhen
11. Lotus Pharmaceuticals to Exhibit at the 63rd PHARMCHINA
Post Your Comments:
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):